Aquestive Therapeutics (AQST) Other financing activities (2017 - 2025)

Aquestive Therapeutics' Other financing activities history runs 7 years deep, the most recent figure standing at $7000.0 for Q3 2025.

• In Q3 2025, Other financing activities fell 12.5% year-over-year to $7000.0; the TTM figure through Sep 2025 stood at $3000.0 (up 100.04% YoY), while the FY2023 annual figure was $4.6 million, changed N/A from the prior year.
• Other financing activities was $7000.0 for Q3 2025 at Aquestive Therapeutics, down from $8000.0 in the prior quarter.
• In the past five years, Other financing activities ranged from a high of $9.1 million in Q1 2023 to a low of -$7.9 million in Q4 2023.
• Historically, Other financing activities has averaged $424000.0 across 3 years, with a median of $6000.0 in 2025.
• Biggest YoY gain for Other financing activities was 99.77% in 2024; the steepest drop was 99.94% in 2024.
• A 3-year view of Other financing activities shows it stood at -$7.9 million in 2023, then soared by 99.77% to -$18000.0 in 2024, then jumped by 138.89% to $7000.0 in 2025.
• The last three Other financing activities figures came in at $7000.0 (Q3 2025), $8000.0 (Q2 2025), and $6000.0 (Q1 2025), per Business Quant data.